BPSD

GuideStar Eldercare Expands Capacity to Serve Texas, Ohio, Chicago

Retrieved on: 
Thursday, April 4, 2024
Other Health, Research, Managed Care, General Health, Consumer, Mental Health, Science, Nursing, Neurology, Seniors, Practice Management, Health, Diagnosis, BPSD, Growth, Candid (organization), EVP, Associate, General counsel, Knowledge, Cutler, Behavior, MD, Quality of life, Region, CMS, Corporation, Hospital

Services are also being opened up to the greater Chicago metro area in Illinois, said Posar.

Key Points: 
  • Services are also being opened up to the greater Chicago metro area in Illinois, said Posar.
  • Corporate leadership expansion includes the promotions of Maureen M. Maloney to President & Chief Operating Officer and Sima Cutler, Esq.
  • Their promotions increase GuideStar Eldercare’s capacity to serve long-term care organizations, he added.
  • The GuideStar Eldercare team reduces suffering while advancing dignity, functionality, and quality of life for geriatric residents of our nation’s long-term care facilities.

Trafigura Selects IsoTherming® Technology for Grassroots Diesel Hydrotreater

Retrieved on: 
Wednesday, September 6, 2023
Environment, Other Energy, Utilities, Chemicals, Plastics, Oil, Gas, Sustainability, Alternative Energy, Manufacturing, Green Technology, Energy, BPSD, Clean technology, Business development, FCC, Life, Hydrogen, Carbon, GTL, VGO, LCO, Engineering, Particulates, Vaca Muerta, Pleasure, OPEX, Heat, Transport, Nitrogen, CO2, IsaKidd refining technology, ULSD, Natural gas, Jet fuel, Trafigura

This groundbreaking project represents a major investment by Trafigura in expanding the refinery’s diesel capacity and enhancing its ability to produce and sell ultra-low sulfur diesel (ULSD) domestically.

Key Points: 
  • This groundbreaking project represents a major investment by Trafigura in expanding the refinery’s diesel capacity and enhancing its ability to produce and sell ultra-low sulfur diesel (ULSD) domestically.
  • IsoTherming® technology is the lowest available carbon intensity technology on the market which will reduce the refinery's total carbon footprint.
  • Not only does this technology enhance the quality of diesel fuel by efficiently removing sulfur, nitrogen, and other impurities, but it also has much lower carbon emissions than a traditional hydroprocessing unit.
  • The addition of the diesel hydrotreater is expected to provide significant advantages to Trafigura, the Bahía Blanca Refinery, and the country of Argentina.

USCIB Foundation Launches Campaign to Promote Vaccine Literacy, Workplace Wellbeing

Retrieved on: 
Monday, November 28, 2022
COVID-19, Communication, Learning, Campaign, COVID19, Multimedia, Partnership, Trust, United States Council for International Business, Coalition, Movement, BPSD, Sustainable development, USCIB, Business partnering, Vaccination, Health, Research, Engagement, International business, Vaccine, Business, Pharmaceutical industry, Management

NEW YORK, Nov. 28, 2022 /PRNewswire/ -- Today, the USCIB Foundation launched the 'There's More To Be Done' Campaign, an initiative that seeks to maintain workplace wellbeing.

Key Points: 
  • NEW YORK, Nov. 28, 2022 /PRNewswire/ -- Today, the USCIB Foundation launched the 'There's More To Be Done' Campaign, an initiative that seeks to maintain workplace wellbeing.
  • The Campaign includes free Learning Modules for employers that incorporates training videos, action steps, learning objectives and resources.
  • The Campaign:
    Identifies the role of vaccines in creating a safer workplace and employee well-being.
  • ABOUT THE USCIB FOUNDATION: The USCIB Foundation is the research and educational arm of the United States Council for International Business (USCIB).

MediCane Health Inc. Announce First Patient Enrolled in a Phase IIa Clinical Trial of MediCane’s Balanced T3:C3 Oral Medical Cannabis Oil for Symptom Relief of Behavioral and Psychological Symptoms of Dementia (BPSD)

Retrieved on: 
Thursday, October 20, 2022
Research, Mental Health, Cannabis, Clinical Trials, Biotechnology, Alternative Medicine, Pharmaceutical, Health, Natural Resources, Science, Physician, Caregiver, Laboratory, Tel Aviv Sourasky Medical Center, CBD, Memory, Sheba Medical Center, Thought, Fatigue, BPSD, VP, CIS, GMP, Agitation, Patient, C3, Standard of care, Aggression, Disruptive Behavior Disorders Rating Scale, Behavior, Trial of the century, IBS, Irritable bowel syndrome, Mediterranean tropical-like cyclone, THC, Safety, Syndrome, Geriatric psychiatry, AD, Clinical trial, Medical cannabis, Pharmaceutical industry, Dietary supplement, Insomnia, EU, Dementia

The trial is being conducted in two leading academic hospitals in Israel, Sheba Medical Center and Sourasky Medical Center.

Key Points: 
  • The trial is being conducted in two leading academic hospitals in Israel, Sheba Medical Center and Sourasky Medical Center.
  • A total of 55 subjects will receive MediCanes balanced T3:C3 oral medical cannabis oil extracted from MediCanes proprietary strain and formulated for blinding purposes, on top of standard of care.
  • The mission of MediCane Health Inc. is to develop evidence-based treatments created from cannabis plants in its derived molecules.
  • MediCanes balanced T3:C3 oil is an oral medical cannabis oil extracted from MediCanes proprietary strain in GMP-grade olive oil, which is based on a marketed balanced T3:C3 (THC:CBD) MediCane product.

KBR's Market-Leading ROSE Technology Selected by CPC Corporation

Retrieved on: 
Wednesday, April 13, 2022
Carbon, COVID-19, Risk, Natural gas, U.S. Securities and Exchange Commission, Annual report, Compliance, Dislocation, Engineering, Intellectual property, VDU, Carbon footprint, Terrorism, Contract, KBR, CPC Corporation, Solution, Maintenance, Tax, NYSE, SDA, Solvent, Income, Multimedia, Industry, CPC, View, BPSD, ROSE, Renewable energy, Risk management, Technology

HOUSTON, April 13, 2022 /PRNewswire/ -- KBR (NYSE: KBR) announced today that it has been awarded a contract for its ROSE supercritical Solvent De-Asphalting (SDA) technology and Vacuum Distillation Unit (VDU) from Taiwan's state-owned oil company, CPC Corporation.

Key Points: 
  • HOUSTON, April 13, 2022 /PRNewswire/ -- KBR (NYSE: KBR) announced today that it has been awarded a contract for its ROSE supercritical Solvent De-Asphalting (SDA) technology and Vacuum Distillation Unit (VDU) from Taiwan's state-owned oil company, CPC Corporation.
  • Under the terms of the contract, KBR will provide a license, basic engineering and proprietary equipment to CPC for its proprietary ROSE technology.
  • ROSE technology is a cost-effective residue upgrading process that allows refiners to produce higher grade, cleaner products while reducing the facility's carbon footprint.
  • "We are pleased to work with CPC on this important project that enables clean fuels production with KBR's energy-efficient and sustainable ROSE process," said Doug Kelly, KBR President, Technology.

Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany

Retrieved on: 
Friday, April 1, 2022
Other Retail, Specialty, Biotechnology, Alternative Medicine, Health, Pharmaceutical, Retail, Agriculture, Natural Resources, Pandemic, NSE, CAGR, Aggression, Bundestag, NYSE, Psychosis, Risk, Wickham Laboratories Ltd, Disease, GMP, Annual report, Education, Security (finance), Purging disorder, Marketing, Spasticity, Dermatology, Laboratory, German Parliament Police, Quality of life, GACP, Industry, Cyprus Securities and Exchange Commission, Vomiting, Agitation, Apathy, Growth, Multimedia, Clinical trial, Mortality, Coronavirus, Epidemic, Risk factors of schizophrenia, BTB, Pain management, BPSD, BSE, Patient, Partnership, Behavior, 25, Group, API, D, BTC, Lists of disasters, EU, Mission statement, CIS, COVID-19, Mediterranean tropical-like cyclone, Depression, Acquisition, RDY, Generic drug, Medical device, Pharmaceutical industry, Dementia

For Dr. Reddy's, the launch reinforces its presence in Germany's growing medical cannabis market, building on its recent acquisition of Nimbus Health GmbH that specializes in the distribution, registration, sales and marketing of medical cannabis.

Key Points: 
  • For Dr. Reddy's, the launch reinforces its presence in Germany's growing medical cannabis market, building on its recent acquisition of Nimbus Health GmbH that specializes in the distribution, registration, sales and marketing of medical cannabis.
  • The demand for medical cannabis has increased over the past years, driven by the German Parliament's (Bundestag) legalization of medical cannabis in 2017.
  • Patrick Aghanian, Head of European Generics, Dr. Reddy's, said: "This collaboration with MediCane Health demonstrates Dr. Reddy's commitment to take a leadership position in Europe's rapidly growing medical cannabis market.
  • With MediCane, we join forces with a unique and differentiated research-based partner in the medical cannabis field.

Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany

Retrieved on: 
Friday, April 1, 2022
Research, Tobacco, Biotechnology, Alternative Medicine, Health, Pharmaceutical, General Health, Retail, Science, Vomiting, NSE, CAGR, Purging disorder, Aggression, Agitation, Apathy, Bundestag, Behavior, 25, Group, Marketing, API, D, Growth, Spasticity, Clinical trial, NYSE, Psychosis, BTC, BTB, Wickham Laboratories Ltd, Dermatology, Laboratory, German Parliament Police, EU, BPSD, Pain management, Quality of life, GACP, CIS, Mediterranean tropical-like cyclone, GMP, BSE, Education, Depression, Acquisition, Patient, RDY, Partnership, Generic drug, Medical device, Pharmaceutical industry, Dementia

As part of a collaboration between Dr. Reddy's and MediCane that started in 2021, MediCane will supply the medical cannabis products to Dr. Reddy's from its EU-GMP-certified facilities in Portugal along with providing logistical and regulatory support.

Key Points: 
  • As part of a collaboration between Dr. Reddy's and MediCane that started in 2021, MediCane will supply the medical cannabis products to Dr. Reddy's from its EU-GMP-certified facilities in Portugal along with providing logistical and regulatory support.
  • For Dr. Reddy's, the launch reinforces its presence in Germany's growing medical cannabis market, building on its recent acquisition of Nimbus Health GmbH that specializes in the distribution, registration, sales and marketing of medical cannabis.
  • The demand for medical cannabis has increased over the past years, driven by the German Parliament's (Bundestag) legalization of medical cannabis in 2017.
  • Using a patient-centric approach to clinical trials, MediCane aims to provide potent cannabis-based pharmaceutical products to treat inflammatory and neurological diseases.

RefiPampa Contracts Elessent Clean Technologies for IsoTherming® Hydroprocessing Technology

Retrieved on: 
Tuesday, March 15, 2022
Other Energy, Oil, Gas, Environment, Other Manufacturing, Energy, Engineering, Chemicals, Plastics, Manufacturing, Technology, LCO, Â, Kerosene, OPEX, VGO, FCC, Life, BPSD, Clean technology, CO2, GTL, Carbon, SM, Hydrogen, Engineering, Oil, La Pampa Province

Refi Pampa SA (RefiPampa) has signed agreements with Elessent Clean Technologies (Elessent) for the license and basic engineering of a new IsoTherming Diesel Hydrotreating and Dewaxing Unit.

Key Points: 
  • Refi Pampa SA (RefiPampa) has signed agreements with Elessent Clean Technologies (Elessent) for the license and basic engineering of a new IsoTherming Diesel Hydrotreating and Dewaxing Unit.
  • IsoTherming hydroprocessing units are designed to provide refiners with consistent 30-60 percent savings on utilities compared to trickle bed technologies and the potential of 30 percent capital cost savings or more.
  • The IsoTherming hydroprocessing technology utilizes a novel liquid-phase reactor system offering distinct advantages over conventional hydroprocessing technologies in that it uses hydrogen and catalyst more efficiently.
  • Elessent Clean Technologies, the Elessent Logo, and all trademarks and service marks denoted with , SM or are owned by affiliates of Elessent Clean Technologies Inc. unless otherwise noted.

MediCane Health Inc. Receives IMC-GMP License for its Manufacturing Plant in Israel

Retrieved on: 
Thursday, February 3, 2022
Biotechnology, Alternative Medicine, Health, Manufacturing, Consumer, Other Health, Pharmaceutical, Mental Health, General Health, Other Consumer, Fitness & Nutrition, Other Manufacturing, Seniors, Medical Supplies, Behavior, CEO, BPSD, Patient, Mediterranean tropical-like cyclone, Research, Sleep, Population, Marketing, Pharmaceutical industry, Medicinal plants, Dementia

MediCane Health Inc. is pleased to announce the awarding of an IMC-GMP license for its new manufacturing facility in Kfar Saba, Israel.

Key Points: 
  • MediCane Health Inc. is pleased to announce the awarding of an IMC-GMP license for its new manufacturing facility in Kfar Saba, Israel.
  • The number of patients approved for the use of medical cannabis in Israel has increased steadily, reaching over 100,000 in January 2022.
  • We will soon also produce the first batches for upcoming clinical trials of MediCane later in the year.
  • MediCane Health Incorporated is an international pharmaceutical company engaged in research and development, as well as the cultivation, production, and marketing of cannabis-based medications.

One of the World's Largest Alky Units Achieves Successful Start-up

Retrieved on: 
Thursday, August 12, 2021
Multimedia, Alkylation, Achievement, Clips4Sale, Technology, Lummus, ZPC, Chemical substance, BPSD, Solution, Oil, Gasoline

The unit has a capacity of 45,000 BPSD of alkylate product, making it the largest alkylation unit ever licensed by Lummus.

Key Points: 
  • The unit has a capacity of 45,000 BPSD of alkylate product, making it the largest alkylation unit ever licensed by Lummus.
  • "Given the unit's unique and advanced features, such as the scale and the nature of the feedstock, this achievement reflects Lummus' ability to adapt, innovate and collaborate closely with our customers."
  • Lummus' CDAlky technology is an advanced low-temperature sulfuric acid alkylation process for the production of premium motor fuel alkylate.
  • It reacts light olefin streams from refinery sources such as fluid catalytic cracking units or from steam cracking units with iso-paraffins to produce fuel alkylate.